EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, RGNX: Regenxbio Inc

11 Feb 26 17:20
LAST:

8.500

CHANGE:
 0.35		OPEN:
8.810		HIGH:
8.979		ASK:
29.250		VOLUME:
1.09M
CHG(%):
3.95		PREV:
8.850		LOW:
8.210		BID:
15.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
11 Feb 268.8108.9808.2108.5001.09M
10 Feb 269.0209.3108.4008.8502.51M
09 Feb 2610.14010.62010.01010.310955.4K
06 Feb 2610.73010.95010.32010.3301.0M
05 Feb 2610.50011.20010.15010.260961.3K
04 Feb 2610.71010.86010.51010.750759.7K
03 Feb 2610.65011.25910.61010.860701.8K
02 Feb 2610.90011.32010.45010.780817.7K
30 Jan 2611.23011.56010.97011.1601.01M
29 Jan 2610.81011.78010.60111.6001.61M

PROFILE

Name:Regenxbio Inc
About:REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's products in pipeline includes ABBV-RGX-314 for the treatment of wet age-related macular degeneration, diabetic retinopathy, and other chronic retinal diseases; and RGX-202, which is in Phase III clinical trial for the treatment of Duchenne muscular dystrophy, as well as RGX-121 for the treatment of mucopolysaccharidosis type II. It also develops RGX-111 for the treatment of mucopolysaccharidosis type I, RGX-181 for the treatment of late-infantile neuronal ceroid lipofuscinosis type 2, and RGX-381 for the treatment of the ocular manifestations of CLN2 disease. In addition, the company licenses its NAV Technology Platform to other biotechnology and pharmaceutical companies. Further, it has a collaboration and license agreement with AbbVie Global Enterprises Ltd. to develop ABBV-RGX-314 outside the United States. REGENXBIO Inc. was incorporated in 2008 and is headquartered in Rockville, Maryland.
Sector:Healthcare
Industry:Biotechnology
Address:9804 Medical Center Drive, Rockville, MD, United States, 20850
Website:https://www.regenxbio.com
CUSIP:75901B107
CIK:0001590877
ISIN:US75901B1070
FIGI:BBG007Z9V591
LEI:549300EOES47LATSET33

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-2.61 
Forward P/E:-7.45 
PEG Ratio:-0.08 
Price to Sales:4.14 
Price to Book:4.78 
Profit Margin:-1.13 
Operating Margin:-2.96 
Return on Assets:-0.18 
Return on Equity:-0.62 
EPS Ratio:-3.46 
Revenue:155.78M 
Shares:50.62M 
Market Cap:430.3M 

TECHNICAL INDICATORS

MA5:9.6513.5%
MA10:10.3421.6%
MA20:12.1442.9%
MA50:13.1754.9%
MA100:12.3244.9%
MA200:10.6024.7%
RSI14:8.86 
WPR14:-100.00 
MTM14:-5.29
ROC14:-0.38 
ATR:1.19 
Week High:11.2031.8%
Week Low:8.213.5%
Month High:16.1990.5%
Month Low:8.2124.7%
Year High:16.1990.5%
Year Low:5.0468.8%
Volatility:82.32